Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.

Pfaller, Michael A

Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. [electronic resource] - Journal of clinical microbiology Aug 2013 - 2571-81 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1098-660X

10.1128/JCM.00308-13 doi


Antifungal Agents--pharmacology
Echinocandins--pharmacology
Fungi--classification
Global Health
Humans
Microbial Sensitivity Tests
Mycoses--microbiology
Triazoles--pharmacology
Yeasts--classification